Efficient antiproliferative and antiangiogenic effects on human ovarian cancer growth by gene transfer of attenuated mutants of Shiga-like toxin I

International Journal of Gynecological Cancer

Volumn 18, Issue 4, 2008, Pages 677-691

  Wei, F ^a   Cao, S ^a   Ren, X ^a   Liu, H ^a   Yu, J ^a   Li, H ^a   Hao, X ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Cell cycle; Cytotoxicity; Endothelial cells; Necrosis; Shiga like toxin I

Indexed keywords

CASPASE; DNA FRAGMENT; LIPOSOME; PLASMID DNA; TOXIN ANTIBODY; VEROTOXIN 1;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL FUNCTION; CELL MIGRATION; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; EXPRESSION VECTOR; FEMALE; GENE TRANSFER; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; RECOMBINANT PLASMID;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIMITOTIC AGENTS; CANCER VACCINES; CARCINOMA; CELL PROLIFERATION; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; FEMALE; GENE THERAPY; HUMANS; MICE; MICE, NUDE; MUTANT PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; SHIGA TOXIN 1; TRANSFECTION; TREATMENT OUTCOME; VACCINES, ATTENUATED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 47649123022     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01090.x     Document Type: Article

References (22)

1. Sandvig K. Shiga toxins. Toxicon 2001 39 : 1629 35.
2. Gariepy J. The use of Shiga-like toxin 1 in cancer therapy. Crit Rev Oncol Hematol 2001 39 : 99 106.
3. Farkas-Himsley H, Hill R, Rosen B et al. The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1. Proc Natl Acad Sci USA, 1995 92 : 6996 7000.
4. Arab S, Lingwood CA. Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to Verotoxin via globotriaosyl ceramide fatty acid isoform traffic. J Cell Physiol 1998 177 : 646 60.
5. Lala P, Ito S, Lingwood CA. Retroviral transfection of Madin-Darby Canine Kidney cells with human MDR1 results in a major increase in globotriaosylceramide and 105 to 106-fold increased cell sensitivity to verocytotoxin. Role for p-glycoprotein in glycolipid synthesis. J Biol Chem 2000 275 : 6246 51.
6. Heath-Engel HM, Lingwood CA. Verotoxin sensitivity of ECV304 cells in vitro and in vivo in a xenograft tumour model: VT1 as a tumour neovascular marker. Angiogenesis 2003 6 : 129 41.
7. Ishitoya S, Kurazono H, Nishiyama H et al. Verotoxin induces rapid elimination of human renal tumor xenografts in SCID mice. J Urol 2004 171 : 1309 13.
8. Nakayama K, Pergolizzi RG, Crystal RG. Gene transfer-mediated pre-mRNA segmental trans-splicing as a strategy to deliver intracellular toxins for cancer therapy. Cancer Res 2005 65 : 254 63.
9. Kovbasnjuk O, Mourtazina R, Baibakov B et al. The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer. Proc Natl Acad Sci USA 2005 102 : 19087 92.
10. Lingwood CA. Verotoxin/globotriaosyl ceramide recognition: angiopathy, angiogenesis and antineoplasia. Biosci Rep 1999 19 : 345 54.
11. Yamasaki S, Furutani M, Ito K et al. Importance of arginine at position 170 of the A subunit of Vero toxin 1 produced by enterohemorrhagic Escherichia coli for toxin activity. Microb Pathog 1991 11 : 1 9.
12. Jaffe E, Nachman R, Becker C et al. Culture of human endothelial cells derived from umbilical cords: identification by morphologic and immunologic criteria. J Clin Invest 1973 52 : 2745 56.
13. Gasparini G, Harris AL. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 1995 13 : 765 82.
14. Tanigawa N, Lu C, Mitsui T et al. Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance. Hepatology 1997 26 : 1216 23.
15. Bendtsen JD, Nielsen H, von Heijne G et al. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 2004 340 : 783 95.
16. Cherla RP, Lee SY, Tesh VL. Shiga toxins and apoptosis. FEMS Microbiol Lett 2003 228 : 159 66.
17. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999 5 : 1249 55.
18. Sauter B, Albert ML, Francisco L et al. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000 191 : 423 34.
19. Steinman RM, Turley S, Mellman I et al. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000 191 : 411 6.
20. Fadeel B. Programmed cell clearance. Cell Mol Life Sci 2003 60 : 2575 85.
21. Bergsmedh A, Szeles A, Henriksson M et al. Horizontal transfer of oncogenes by uptake of apoptotic bodies. Proc Natl Acad Sci USA 2001 98 : 6407 11.
22. Majoul I, Schmidt T, Pomasanova M et al. Differential expression of receptors for Shiga and Cholera toxin is regulated by the cell cycle. J Cell Sci 2002 115 : 817 26.